Cell Death Effects of the Phthalate 2-Ethyl-1-Hexanol on Human Linfoblast Cells

Phthalates have been used in a wide variety of consumer goods. Their versatility as plasticizers has translated into worldwide use in a vast array of consumer products. These compounds can leach into matrices, such as food and liquids that can be routed for human exposure. One of the most used phthalates is Diethylhexyl phthalate (DEHP). Diethylhexyl phthalate and its metabolite 2-ethyl-1-hexanol (2-EH) have demonstrated biological effects which merit further evaluation. In this work, we expand on our previous work with DEHP and screen the 2-EH metabolite for different cell death endpoints such as growth inhibition, apoptosis, autophagy, caspase activation, DNA fragmentation, and cell cycle arrest using fluorophores and the NC3000 instrument. Significant results (p 0.05) revealed higher toxicity for the 2-EH metabolite when compared to DEHP. Also, 2-EH presented apoptosis induction with characteristic hallmarks, such as loss of mitochondrial membrane potential, caspase activation, DNA fragmentation and cell cycle arrest at the S phase. In addition, the presence of autophagosome was detected through L3CB protein staining. We conclude that 2-EH presents differences in cell death endpoints that interestingly differ from the DEHP parent compound. Further studies are needed to establish the molecular pathways responsible for the observed effects.

枯草芽孢杆菌PW2挥发性产物对黄曲霉的抑制作用

为探寻安全、高效的黄曲霉新型抑制物,采用顶空固相微萃取-气质联用(HS-SPME-GC-MS)技术对枯草芽孢杆菌(Bacillus subtilis)PW2所产具有抗霉活性的挥发性有机化合物(volatile organic compounds,VOCs)进行了成分鉴定,并利用平板对扣法从鉴定出的成分中筛选具有强抗霉活性的目标化合物,通过平板对扣法和96孔板梯度稀释法测定目标化合物对黄曲霉的最小抑菌体积分数(MIC),使用黄曲霉毒素B_(1)(aflatoxin B_(1),AFB_(1))ELISA检测试剂盒分析了目标化合物对黄曲霉产AFB_(1)的抑制作用,使用扫描电子显微镜(scanning electron microscope,SEM)观察受试黄曲霉孢子形态的变化和采用分光光度法测定受试黄曲霉细胞膜麦角甾醇相对含量,以探讨抗霉机理。结果显示,从PW2所产VOCs中共鉴定出41种组分,并从中筛选出异辛醇为目标化合物;平板对扣法和96孔板梯度稀释法测得异辛醇对黄曲霉的MIC分别为0.169μL/mL和6.25μL/mL;PDB培养基中异辛醇体积分数分别为3.13、6.25、12.50μL/mL时,均能有效抑制AFB_(1)的产生,且随异辛醇体积分数的升高,抑制效果增强;异辛醇处理可导致黄曲霉孢子表面凹陷和孢子破裂,并且影响细胞膜中麦角甾醇的相对含量,造成细胞膜受损。该研究可为开发以异辛醇为功能成分的黄曲霉抑制剂提供理论参考。

Synthesis, Bioactivity, and Crystal Structure Analysis of 2-(3-Oxobenzo[d]isothiazol-2(3H)-yl)ethyl Benzoates

Fifteen novel 2-（3-oxobenzo[d]isothiazol-2（3H）-yl）ethyl benzoates were synthesi- zed by the condensation of 2-（2-hydroxyethyl）benzo[d]isothiazol-3（2H）-one with substituted benzoic acids in dichloromethane. All the compounds were characterized by elemental analysis, IR, ESI-MS and 1H NMR. The crystal structures for 2-（2-hydroxyethyl）benzo[d]isothiazol-3（2H）-one （2） and 2-（3-oxobenzo[d]isothiazol-2（3H）-yl）ethyl 2-methoxybenzoate （30） have been determined by X-ray crystal structure analysis. Compound 2 （C9H9NO2S） crystallizes in the monoclinic system, space group Pn with a = 10.552（3）, b = 7.849（2）, c = 10.765（4） A, β = 103.128（4）°, V= 868.3（5） A3, Mr = 195.24, Dc = 1.493 Mg.m-3, μ = 0.33 mm-1, F（000） = 408, Z = 4, R= 0.0314 and wR= 0.0628. Compound 30 （C17H15NO4S） crystallizes in the triclinic system, space group P1 with a = 8.028（2）, b = 9.300（2）, c = 10.430（3）A, V= 752.1（3）A3, Mr = 329.36, D,= 1.454 Mg.m-3, p = 0.24 mm-1, F（000） = 344, Z = 2, R = 0.0377 and wR = 0.0904. The preliminary biological test indicated that the title compounds show better growth inhibitory activity against the gram-positive bacteria than the gram-negative bacteria.

Synthesis and Crystal Structure of a Novel Ethyl 5-(4-(2-Phenylacetamido)phenyl)-1H-pyrazole-3-carboxylate as an Acrosin Inhibitor

The title compound （ethyl5-（4-（2-phenylacetamido）phenyl）-lH-pyrazole-3-carboxylate, C20H19N3O3） was synthesized by the reaction of Claisen condensation, cyclization, reduction and acylation. The structure was characterized by X-ray diffraction, MS, NMR and IR. It belongs to the monoclinic system, space group C2/c with a = 22.723（9）, b = 9.324（4）, c = 18.890（8） A, β = 114.259（6）°, V = 3649（3） A^3, Dc = 1.272 Mg·m^3, Z = 8, Mr = 349.38, p = 0.087 mm^-1, F（000） = 1472, the final R = 0.0615 and wR = 0.1643. The biological test shows that the title compound has a moderate acrosin inhibition activity.

Long-term and combined effects of N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide and fumaric acid on methane production,rumen fermentation, and lactation performance in dairy goats

Background:In recent years,nitrooxy compounds have been identified as promising inhibitors of methanogenesis in ruminants.However,when animals receive a nitrooxy compound,a high portion of the spared hydrogen is eructated as gas,which partly offsets the energy savings of CH4mitigation.The objective of the present study was to evaluate the long-term and combined effects of supplementation with N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide(NPD),a methanogenesis inhibitor,and fumaric acid(FUM),a hydrogen sink,on enteric CH4production,rumen fermentation,bacterial populations,apparent nutrient digestibility,and lactation performance of dairy goats.Results:Twenty-four primiparous dairy goats were used in a randomized complete block design with a 2×2factorial arrangement of treatments:supplementation without or with FUM(32 g/d)or NPD(0.5 g/d).All samples were collected every 3 weeks during a 12-week feeding experiment.Both FUM and NPD supplementation persistently inhibited CH4yield(L/kg DMI,by 18.8%and 18.1%,respectively)without negative influence on DMI or apparent nutrient digestibility.When supplemented in combination,no additive CH4suppression was observed.FUM showed greater responses in increasing the molar proportion of propionate when supplemented with NPD than supplemented alone(by 10.2%vs.4.4%).The rumen microbiota structure in the animals receiving FUM was different from that of the other animals,particularly changed the structure of phylum Firmicutes.Daily milk production and serum total antioxidant capacity were improved by NPD,but the contents of milk fat and protein were decreased,probably due to the bioactivity of absorbed NPD on body metabolism.Conclusions:Supplementing NPD and FUM in combination is a promising way to persistently inhibit CH4emissions with a higher rumen propionate proportion.However,the side effects of this nitrooxy compound on animals and its residues in animal products need further evaluation before it can be used as an animal feed additive.

Synthesis, Crystal Structure and Antitumor Activities of N-(2-(1H-indol-3-yl)ethyl)-2-nitroaniline

The title compound, N-(2-(1H-indol-3-yl)ethyl)-2-nitroaniline(C16H15N3O2, Mr = 281.31), has been synthesized by the multicomponent reaction of milder Ullmann, and its structure was characterized by 1H NMR, 13 C NMR, IR, H RMS(ESI) and single-crystal X-ray diffraction. It crystallizes in monoclinic, space group I2/c with a = 15.0212(10), b = 9.4911(6), c = 20.3075(13) A, β = 100.776(7)o, V = 2844.1(3)A3, Z = 8, Dc = 1.314 g/cm3, F(000) = 1184.0, μ = 0.089 mm-1, the final R = 0.0574 and w R = 0.1688 for 1701 observed reflections(I 】 2σ(I)). X-ray analysis indicates three major N(2)–H(2)···O(2), C(13)–H(13)···O(2), N(2)–H(2)···N(3) hydrogen bonds and π-π stacking interactions in the crystal structure. The preliminary biological test shows that the title compound has a good antitumor activity against A549 in vitro with the IC50 value of 35 μmol/L.

Synthesis and Crystal Structure of Ethyl 3-(4-Chlorophenyl)-3,4-dihydro-6-methyl-4-oxo-2-(pyrrolidin-1-yl)furo[2,3-d]pyrimidine-5-carboxylate

The crystal structure of the title compound ethyl 3-（4-chlorophenyl）-3,4-dihydro-6- methyl-4-oxo-2-（pyrrolidin-1-yl）furo[2,3-d]pyrimidine-5-carboxylate （C20H20ClN3O4, Mr= 401.84） has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic, space group P21/n with a = 20.6215（9）, b = 8.5311（4）, c = 21.6886（9） A^°, β = 91.607（1）°, V = 3814.0（3）A^°^3, Z = 8, Dc = 1.400 g/cm^3, F（000） = 1680, μ = 0.233 mm^-1, R = 0.0718 and wR = 0.1545 for 6717 observed reflections with I 〉 2σ（I）. X-ray diffraction analysis reveals two crystallographically independent molecules in the asymmetric unit.

A new free recoverable and reusable mono-alkaloid-type ligand and its use in preparation of ethyl(2R,3S)-2,3-dihydroxy-3-phenylpropionate

A new free recoverable and reusable mono-alkaloid-type ligand has been synthesized by a simple method. With highly polar groups, the ligand can be recycled and reused eight times to prepare ethyl （2R,3S）-2,3-dihydroxy-3-phenylpropionate with high yield and ee via asymmetric dihydroxylation （AD） reaction. C 2009 Sheng Yong Zhang. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.

Identification of N-Methyl Bis(2-(Alkyloxy-Alkylphosphoryloxy)Ethyl) Amines by LC-HRMS/MS

N-Methyl bis(2-(alkyloxy-alkylphosphoryloxy)ethyl)amines, which are abbreviated as PNPs, are a series of new skeleton chemicals belonging to schedule 2.B.04 chemicals of Chemical Weapons Convention (CWC). PNPs are important markers of chemical warfare agents because they are structurally relative to both nerve agents and N-mustards. In this study, fragmentation pathways of the most characteristic fragment ions in Q-TOF mass spectrometry were proposed based on the information from accurate mass and secondary fragmentations of product ions scan experiments. Results indicated that the base ion in LC/HRMS was the quasi-molecular ion [M+H]+. In LC-HRMS/MS, it was [M+H-CnH2n+1P(O)(OH)CmH2m+1O]+ fragment ion which was formed by losing an alkyloxy alkylphosphoryloxy group from the quasi-molecular ion. The diagnostic ion m/z84.0814 was identified as [C5H10N]+, which was the group of (CH2=CH)2N+(H)CH3. PNPs have two protonated centers. One is on the N atom, the other is on the O atom (P=O). O-n-propyl PNPs generally exhibited two fragmentation pathways. Firstly, the quasi-molecular ion [M+H]+ lost a propoxy alkylphosphoryloxy group to produce [R1P(OH+)(O-n-C3H7)OCH2CH2N(CH3)CH=CH2]+, which could be fragmented further to produce [C5H10N]+ ion. Secondly, [R1P(OH+)(O-n-C3H7) OCH=CH2]+ ions were produced from [M+H]+ and fragmented further to produce the abundant ions [R1P(OH+)(OH)OCH =CH2]. However, O-isopropyl PNPs characteristically produced weak fragment ions [M+H-C3H6]+, which were presumably formed via loss of CH3CH=CH2 from [M+H]+. Other PNPs showed similar fragmentation pathways as O-n-propyl PNPs. On the summarization of the MS fragmentation pathways of PNPs, LC-HRMS/MS quantitative and qualitative methods were developed and applied to analyze N-Methyl bis(2-(butoxy-methylphosphoryloxy)ethyl]amine in high background organic samples. The analytical results had successfully supported the sample preparation for the 33rd official proficiency test of Organization for Prohibition of Chemical Weapons (OPCW).

Synthesis and Crystal Structure of 4-(4,6-Dimethoxylpyrimidin-2-yl)-3-thiourea Carboxylic Acid Ethyl Ester

4-（4,6-Dimethoxyl-pyrimidin-2-yl）-3-thiourea carboxylic acid ethyl ester was synthesized by the reaction of 2-amino-4,6-dimethoxyl pyrimidine, potassium thiocyanate and methyl chloroformate in ethyl acetate. Single crystals suitable for X-ray measurement were obtained by recrystallization with the solvent of dimethyl formamide at room temperature. The crystal structure was determined by X-ray diffraction analysis. Crystallographic data： C10H14N4O4S, M, = 286.31, monoclinic, space group C2/c with a = 2.5309（3）, b = 0.67682（6）, c = 1.74237（19） nm, β = 114.744（3）°, V= 2.7106（5） nm3, Dc = 1.403 g/cm3, p = 0.225 mm-1, F（000） = 1200, Z= 8, R= 0.0514 and wR= 0.1529.

Synthesis and Crystal Structure of Ethyl 2-(6-(1,3-Dioxo-4,5,6,7-tetrahydro-1H-isoindol-2(3H)-yl)-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl) Butanoate

The title compound ethyl 2-（6-（1,3-dioxo-4,5,6,7-tetrahydro-lH-isoindol-2（3H）- yl）-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4（3H）-yl） butanoate 3 was synthesized by the reaction of ethyl 2-（6-amino-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4（3H）-yl） butanoate with 4,5,6,7- tetraydrophthalic anhydride, and its structure was determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P2 1/n with a = 9.3469（2）, b = 16.7715（5）, c = 13.7153（4） A, β= 104.9680（10）°, μ = 0.107 mm^-1, Mr = 430.42, V= 2077.08（10） ,A3, Z= 4, Dc = 1.376 g/cm3, F（000） = 904, T= 296（2） K, R = 0.0508 and wR = 0.1478.

Synthesis of Temperature- and pH-Sensitive Graft Copolymer Containing 2-(Diethylamino)ethyl Methacrylate and N-Vinylcaprolactam onto Silicone Rubber

Silicone rubber films were modified by the consecutive grafting of 2-(diethylamino)ethyl methacrylate (DEAEMA) and N-vinylcaprolactam (NVCL) using direct method on two steps with gamma-rays. The effect of absorbed dose and monomer concentration on grafting degree was determined. The grafted samples were verified by FTIR-ATR spectroscopy and swelling;thermal properties were analyzed by DSC and TGA. The stimuli-responsive behavior was studied by swelling and/or DSC. Thermo- and pH-sensitive films of (PP-g-DEAEMA)-g-NVCL presented a pH critical at 3.2 and LCST around 63.5℃.

2-乙基己醇萃取-原子吸收光谱法测定微量镓

在 7.0 mol/L盐酸介质中 ,在抗坏血酸存在下 ,用 2 -乙基己醇萃取试样溶液中的酸性铬蓝 K-镓的络合物 ,然后用 30 g/L 的硫脲将络合物反萃取到水相中 ,用 FAAS法测定镓 ,据此建立了萃取反萃取 - FAAS法测定微量镓的新方法。方法线性范围为 0～ 60 .0 mg/L,灵敏度为 0 .2 8mg/L/1 %。

改性β沸石催化剂上己二酸与2-乙基己醇的酯化反应

用改性β沸石作催化剂，研究了己二酸与２－乙基己醇的酯化反应，讨论了阳离子交换度、焙烧温度及表面酸性对催化活性的影响。结果表明，己二酸二异辛酯的产率随离子交换度的增加而增加，Ｈβ沸石催化剂的焙烧温度为５００℃时，己二酸二异辛酯的产率有一极大值；在同样反应条件下。

S_2O_8^(2-)／ZnO催化废聚酯醇解制备对苯二甲酸二辛酯

制备了S_2O_8^(2-)/ZnO固体超强酸催化剂,并用于催化废聚酯醇解合成对苯二甲酸二辛酯(DOTP)。用XRD、SEM、XPS、FT-IR等对S_2O_8^(2-)/ZnO的结构和性能进行了表征,考察了固体超强酸制备条件对其催化性能的影响。结果表明,673K焙烧5h所得超强酸S_2O_8^(2-)/ZnO催化性能稳定,废聚酯与异辛醇在210～220℃反应3h,DOTP收率可达91．6%以上。

膦酸盐改性的磺化聚苯乙烯负载型新型固体酸催化合成己二酸-2-乙基己酯

用膦酸盐改性的磺化聚苯乙烯负载型新型固体酸催化剂代替传统的液体酸催化剂合成己二酸 2 乙基己酯 ,探讨了催化剂用量及反应条件对酯化反应的影响 ,得出了该反应的最佳条件为 :催化剂用量为 2 g ,2 乙基己醇0 5mol,己二酸 0 1mol,二甲苯带水剂 15mL ,反应温度 16 5℃ ,反应时间 2h ,酯最高收率超过 97 8%.催化剂可以连续重复使用 11次 ,催化活性无明显降低 .

水-乙酸-2-乙基己醇三元体系液液平衡测定及关联

测定了常压下２８８．１５Ｋ、２９３．１５Ｋ、２９８．１５Ｋ及３０３．１５Ｋ时水－乙酸－２－乙基己醇三元体系的液液平衡数据，并用ＮＲＴＬ模型对实验数据进行关联。关联结果与实验数据符合良好。

磷酸二(2-乙基己基)酯的合成与应用研究

研究了磷酸二(2-乙基己基)酯的特性,概述了磷酸二(2-乙基己基)酯的合成方法,详细介绍了磷酸二(2-乙基己基)酯作为萃取剂、阻垢剂、阻燃剂、阻燃偶联剂、抗静电剂、渗透剂、分散剂、表面活性剂、有机合成中间体等方面的应用。磷酸二(2-乙基己基)酯有着广阔的应用和发展前景。

电子和空间位阻效应促进铱配合物催化1-丁醇经Guerbet反应选择制备2-乙基己醇

2-乙基己醇是一种增塑剂醇,可用于合成增塑剂、表面活性剂和溶剂等诸多化工领域.目前工业上2-乙基己醇的合成是以化石资源丙烯为原料,与氢气和一氧化碳通过氢甲酰化反应制备1-丁醛,后者经羟醛缩合和催化加氢反应生成2-乙基己醇.由生物质发酵产生的1-丁醇为原料,只需要经Guerbet反应可一步直接生成2-乙基己醇.比较而言, Guerbet反应路线步骤更少,且1-丁醇原位脱氢产生的氢为氢源,无需额外氢,因此比化石资源丙烯路线对环境友好.目前,文献报道的非均相催化1-丁醇Guerbet反应条件苛刻(如温度> 170 ℃),副产物多(如烯烃、醚和高碳醇等),且均相催化剂的活性低.本文报道了一类Cp*Ir(Cp*为1,2,3,4,5-五甲基环戊二烯基)配合物用于该Guerbet反应.当Cp*Ir配合物的配体上修饰给电子基N,N-二甲基氨基和邻羟基时, Cp*Ir配合物的催化活性增强,催化剂的转化数最高达到了14047.当氢氧化钾和Cp*Ir配合物(配体上修饰了N,N-二甲基氨基和邻羟基官能团)在1-丁醇中的浓度分别为1.7mol%和0.04wt%时,在130 ℃反应48 h,产物2-乙基己醇收率为23.9%,选择性为89.5%.核磁(NMR)研究结果表明, Cp*Ir配合物配体上的邻羟基与氢氧化钾反应脱除质子,生成了羰基结构配体配位的Cp*Ir配合物,继续催化1-丁醇脱氢反应.机理研究表明,中间产物2-乙基己醛α-碳上乙基的位阻效应和2-乙基己烯醛本身的共轭效应抑制了其继续发生羟醛反应,从而提高了目标产物的选择性.

2-乙基己基葡糖苷的合成及其性能测试

以2-乙基己醇和无水葡萄糖为原料,三元酸为催化剂,采用一步法合成2-乙基己基葡糖苷。分别考察了催化剂用量、反应温度、醇糖摩尔比对制备2-乙基己基葡糖苷的影响。结果表明,三元酸催化剂与葡萄糖的质量比为0.054∶1、反应温度为95℃、醇糖摩尔比为5∶1的条件下,糖苷产率为156.42%。同时,对所得产品进行了表征及性能测试,证明了合成物质为2-乙基己基葡糖苷,且是一种高活性、低泡型表面活性剂。